APGAR AS A RISK FACTOR FOR RETINOPATHY OF PREMATURITY (ROP)

Main Article Content

Athokpam Poireiton
Avirupa Kansha Banik

Keywords

APGAR Score, retinopathy of prematurity, preterm, infants, low birth weight

Abstract

Background:


Retinopathy of prematurity (ROP) is a vasoproliferative disorder affecting developing retinal vessels in preterm infants, ranging from mild, non–vision-threatening sequelae to bilateral retinal detachment and blindness. The APGAR score, assessed at 1 and 5 minutes after birth, is a widely used index of neonatal well-being and response to resuscitation. While low birth weight and prematurity are established risk factors for ROP, the association between APGAR scores and ROP risk requires further exploration.


Methods


A total of 200 preterm infants (<36 weeks gestation, <1800 g birth weight) were evaluated. APGAR scores were recorded at 1 and 5 minutes, and fundus examination was performed using an indirect ophthalmoscope to screen for ROP.


Results


All neonates had APGAR scores ≥3 at 1 minute. Infants who developed ROP demonstrated significantly lower APGAR scores at both 1 and 5 minutes compared with those without ROP (P <0.0001).


Conclusion


Low APGAR scores at 1 and 5 minutes are significantly associated with the development of ROP in preterm infants. Routine documentation of APGAR scores and targeted screening of neonates with persistently low scores may facilitate early detection and timely intervention.


 

Abstract 22 | PDF Downloads 4

References

1. Isenberg SJ. Eye disorders. In MacDonald MG, Mullet MD, Seshia MMK, editors. Avery’s Neonatology-Pathophysiology and Management of the New-born. 6th ed. Philadelphia, PA: Lippincott Williams and Wilkins; p.1469-84.
2. Prendiville A, Schulenburg WE. Clinical factors associated with retinopathy of prematurity. Arch Dis Child 1988; 63:522-7.
3. Rekha S, Battu RR. Retinopathy of prematurity incidence and risk factors. Indian Pediatr 1996;33(12):999-1003
4. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicentre trial of cryotherapy for retinopathy of prematurity. Snellen visual acuity and structural outcome at 5 1/2 years after randomization. Arch Ophthalmol 1996; 114:417-24.
5. Reynolds JD, Hardy RJ, Kennedy KA, Spencer R, van Heuven WA, Fielder AR. Lack of effi cacy of light reduction in preventing retinopathy of prematurity. Light Reduction in Retinopathy of Prematurity (LIGHT-ROP) Cooperative Group. N Engl J Med 1998; 338:1572-6.
6. International committee for the classification of retinopathy of prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol 2005; 123:991-9.
7. Gopal L, Sharma T, Ramachandran S, Shanmugasundaram R, Asha V. Retinopathy of prematurity: A study. Indian J Ophthalmol 1995; 43:59-61.
8. Dogra MR, Sanghi G, Zadeng Z, Vinekar A, Das P, Dutta S, et al. Maternal and neonatal risk factors for developing retinopathy of prematurity in preterm infants weighing greater that 1250 g at birth. AIOC Proceedings;2009. p. 478-80.
9. Vanderveen DK, Zupancic JAF. Retinopathy of Prematurity. In: Cloherty JP, Eichenwald EC, Stark AR, editors. Manual of neonatal care. 6th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2010. p.640-4.
10. Singh M. Miscellaneous conditions: Retinopathy of prematurity. In: Care of the new born. 7th ed. New Delhi: Sagar Publications; 2010. p.425-8.
11. Terry TL. Extreme prematurity and fibroblastic overgrowth of persistent vascular growth behind each crystalline lens. Am J Ophthalmology 1942; 25:203-5.